Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models

作者：Osman Erkan Y; Miller Madeline R; Robbins Kate L; Lombardi Abby M; Atkinson Arleigh K; Brehm Amanda J; Lorson Christian L^*

来源：Human Molecular Genetics, 2014, 23(18): 4832-4845.

DOI：10.1093/hmg/ddu198

Spinal muscular atrophy (SMA) is a neurodegenerative disease caused by the loss of Survival Motor Neuron-1 (SMN1). In all SMA patients, a nearly identical copy gene called SMN2 is present, which produces low levels of functional protein owing to an alternative splicing event. To prevent exon-skipping, we have targeted an intronic repressor, Element1 (E1), located upstream of SMN2 exon 7 using Morpholino-based antisense oligonucleotides (E1(MO)-ASOs). A single intracerebroventricular injection in the relatively severe mouse model of SMA (SMN Delta 7 mouse model) elicited a robust induction of SMN protein, and mean life span was extended from an average survival of 13 to 54 days following a single dose, consistent with large weight gains and a correction of the neuronal pathology. Additionally, E1(MO)-ASO treatment in an intermediate SMA mouse (SMNRT mouse model) significantly extended life span by similar to 700% and weight gain was comparable with the unaffected animals. While a number of experimental therapeutics have targeted the ISS-N1 element of SMN2 pre-mRNA, the development of E1ASOs provides a new molecular target for SMA therapeutics that dramatically extends survival in two important pre-clinical models of disease.

• 出版日期2014-9-15